Stocks · Health care · Pharmaceutical Preparations

Alkermes plc.

ALKS Clue Score59
Ireland Fiscal year ends December CIK 0001520262 Results filed 3 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
David Angelo Daglio Jr.
14 Nov 2022
Director
Buy indirect
35,000
$23.31
$815.73K
nancy lynn MD snyderman
4 Mar 2022
Director
Buy
427
$23.43
$10.00K
Emily Peterson Alva
23 Aug 2021
Director
Buy
1,650
$30.22
$49.86K
Brian P McKeon
2 Aug 2021
Director
Buy indirect
10,000
$26.43
$264.27K
Nancy Wysenski
24 Feb 2020
Director
Buy indirect
6,940
$19.65
$136.37K
Nancy Wysenski
14 Mar 2019
Director
Buy indirect
445
$33.06
$14.71K
Nancy Wysenski
21 Feb 2019
Director
Buy indirect
3,857
$33.09
$127.63K
Showing 250 of 294 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 652
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 221
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 9,435,935
Sales filed before the plan box existed 12
History held since 20 Sep 2011